|
Vaccine Detail
Yersinia pestis nlpD mutant vaccine |
Vaccine Information |
- Vaccine Name: Yersinia pestis nlpD mutant vaccine
- Target Pathogen: Yersinia pestis
- Target Disease: Plague
- Vaccine Ontology ID: VO_0002942
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- nlpD
gene engineering:
- Type: Gene mutation
- Description: This nlpD mutant is from Yersinia pestis (Tidhar et al., 2009).
- Detailed Gene Information: Click Here.
- Immunization Route: subcutaneous injection
|
Host Response |
Mouse Response
- Persistence: An nlpD mutant is highly attenuated in mice (Tidhar et al., 2009).
- Efficacy: An nlpD mutant induced significant protection from challenge with wild type Y. pestis in mice (Tidhar et al., 2009).
- Host TNF-alpha response
- Description: The nlpD-null mutant preserves the ability to translocate Yop effectors into host cells as evidenced by suppression of TNF-α secretion from infected RAW264.7 macrophages as compared to other mutant strains. TNF-alpha levels were similar to the levels found in wild type infection, which was significantly less than Yop mutants (Tidhar et al., 2009).
- Detailed Gene Information: Click Here.
|
References |
Tidhar et al., 2009: Tidhar A, Flashner Y, Cohen S, Levi Y, Zauberman A, Gur D, Aftalion M, Elhanany E, Zvi A, Shafferman A, Mamroud E. The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague. PloS one. 2009; 4(9); e7023. [PubMed: 19759820].
|
|